The site will be unavailable in 41 minutes for scheduled maintenance.

Ligand Pharmaceuticals, Inc. (NASDAQ:LGND)

CAPS Rating: 2 out of 5

Develops and markets new drugs that address critical unmet medical needs in the areas of cancer, mens and womens health, skin diseases, osteoporosis, and metabolic, cardiovascular and inflammatory diseases.


Player Avatar TerryHoodSr (58.50) Submitted: 12/27/2012 11:10:32 AM : Outperform Start Price: $21.32 LGND Score: -11.57

TP $27

Featured Broker Partners